Investor Overview

Corporate Profile

Zai Lab (NASDAQ: ZLAB) is a Shanghai-based innovative biopharmaceutical company focused on bringing transformative medicines for cancer, autoimmune and infectious diseases to patients in China and around the world. The company's experienced team has secured partnerships with leading global biopharma companies, generating a broad pipeline of innovative drug candidates targeting the fast growing segments of China's pharmaceutical market and global unmet medical needs. Zai Lab's vision is to become a fully integrated biopharmaceutical company, discovering, developing, manufacturing and commercializing its partner's and its own products in order to impact human health worldwide.

Stock Quote

Volume
Day Low/High
/
52 - Week Low/High
/

Copyright West LLC. Minimum 15 minutes delayed.

Investor & Media Contacts

Zai Lab
Billy Cho, CFO
+86 137 6151 2501
billy.cho@zailaboratory.com

Media Inquiries
Nancie Steinberg / Robert Flamm
212-213-0006, ext. 318 / 364
nsteinberg@burnsmc.com / rflamm@burnsmc.com

Investor Inquiries
Jill Steier
212-213-0006, ext. 367
jsteier@burnsmc.com